Author:
Bagci Ozkan,Tumer Sait,Altungoz Oguz
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Developmental Biology,General Medicine
Reference74 articles.
1. Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Benard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Aleš V, Van Roy N, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJL, Potschger U, Ambros PF (2011) A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17:792–804
2. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM (2005) Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353:2243–2253
3. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245–255
4. Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T (2008) MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci 1:50–56
5. Beckers A, Van Peer G, Carter DR, Althoff K, Cheung BB, Schulte JH, Mestdag P, Vandesompele J, Marshall GM, De Preter K (2015) MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation. Oncotarget 6:5204–5216
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献